Biotech Acquisition Company announced the pricing of its $200 million IPO this evening and its shares are expected to begin trading on the Nasdaq under the symbol “BIOTU” Tuesday, January 26.
The new company intends to focus their search on target businesses in the healthcare sector, with a particular focus on life sciences/biotechnology, healthcare information technology, medical technology and technology-enabled healthcare services. Biotech Acquisition Company is led by Chief Executive Officer and Chairman Dr. Michael Shleifer, COO Ivan Jarry, Chief Investment Officer and Director Albert F. Hummel, and CFO and Treasurer Thomas Fratacci.
Total SPAC deal count for 2021 year-to-date is now 69 with $19.56 billion in gross proceeds raised. This offering is expected to close on Thursday, January 28.
Cantor Fitzgerald & Co. is serving as book-running manager for the offering. Ellenoff Grossman & Schole LLP is serving as Issuer’s Counsel with Reed Smith LLP serving as Underwriter’s Counsel. Marcum LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
At the SPAC of Dawn There are signs that the macro environment for SPACs is gradually improving, but the Screaming Eagle team yesterday announced a non-redemption agreement for its combination with Lionsgate Studios. Such agreements are generally a lever one pulls when a SPAC expects a potentially turbulent closing. All in all, the terms for...
Israeli tech firms have made up an outsized proportion of SPAC activity and despite the ongoing tensions in its region, that dealmaking is continuing unabated. In fact, the SPAC named for the particular mission of taking Israeli firms public through SPACs, Israel Acquisition Corp. (NASDAQ:ISRL) in fact just took one step closer in completing that...
At the SPAC of Dawn Although the market has largely recovered from a negative stretch last week, the roller coaster is tilted back downward for Trump Media (NASDAQ:DJT), which slid -8% yesterday to $32.57 – one of its lowest points since closing with Digital World last month. Other SPACs and de-SPACs are having a more...
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...